Not exact matches
This high mortality is primarily caused by resistance to therapy and the diagnosis of
ovarian cancer after it has already metastasized, which occurs in approximately 80 percent of
patients.
Dr. Tordjman and her colleagues studied the effect of radioactive iodine treatment on the
ovarian reserve of women treated for differentiated thyroid
cancer (DTC) by measuring their blood levels of anti-Müllerian hormone (AMH) and following the
patients for up to one year
after treatment.
Patients with stage 2, 3, and 4
ovarian cancer who are in complete remission
after first - line treatment;
Platinum - sensitive
ovarian cancer patients with a positive predictive AGO score who undergo a secondary debulking surgery
after relapse on platinum chemotherapy experience longer progression - free survival.
New Standard of Care A 50 - year - old method for delivering chemotherapy directly into the abdomen was reevaluated for
patients with
ovarian cancer after a seven - year study of more than 400
patients revealed increased survival rates in
patients with advanced
ovarian cancer.
Olaparib is a PARP inhibitor, which is already used to treat certain
ovarian cancer patients and prevents damaged
cancer cells from repairing themselves
after chemotherapy or radiotherapy.
Sleep disturbance, distress, and quality of life in
ovarian cancer patients during the first year
after diagnosis